Slayback Pharma Appoints Abhijit Mukherjee as Senior Advisor
Apr. 02, 2018
PRINCETON, N.J.--(BUSINESS WIRE)--Apr 2, 2018--Slayback Pharma, LLC (“Slayback”), a privately held pharmaceutical research and development company, announced today the appointment of Abhijit Mukherjee as a Senior Advisor to the Board and Management of Slayback, effective immediately. In this role, Abhijit will advise the company on strategic and operational matters.
"There are very few leaders like Abhijit who have the rare ability of appreciating the smallest details while still maintaining a sharp understanding of the big picture. Abhijit's leadership experience in the pharmaceutical industry as well as his ability to connect the dots will be extremely valuable to the company. I am personally delighted to be working with him again,” said CEO Ajay Singh.
Abhijit Mukherjee is a seasoned veteran in the pharmaceutical industry with a proven track record. For more than 15 years, Abhijit held a number of leadership roles at Dr. Reddy’s Laboratories Ltd, most recently serving as Chief Operating Officer leading operations of the company’s businesses globally. Abhijit has a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology Kharagpur.
ABOUT SLAYBACK PHARMA LLC
Slayback is a New-Jersey based pharmaceutical company focused on the development of complex generic and specialty pharmaceutical products.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180402005132/en/
Slayback Pharma, LLC
Ajay Singh, 609-945-3443
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL GENERAL HEALTH
SOURCE: Slayback Pharma, LLC
Copyright Business Wire 2018.
PUB: 04/02/2018 08:00 AM/DISC: 04/02/2018 08:01 AM